Author(s) |
(a) Bedigian MP, Estacio RO, Jeffers BW, Biggerstaff S, Schrier RW
(b) Bedigian MP
|
 |
Title(s) |
(a) Baseline characteristics of the hypertensive cohort of the Appropriate Blood pressure Control in Diabetes trial-Part 2 with Valsartan (ABCD-2V)
(b) Improving the prognosis of diabetic patients: evaluating the role of intensive versus moderate blood pressure control with selective angiotensin II receptor blocker (ARB) therapy
|
|
Reference(s) |
(a) Am J Hypertens 2000;13 Suppl 1:S56-7 (b) JRAAS 2000;1 Suppl 2:S25-8 |
|
Disease |
Type 2 diabetes with/without hypertension
|
|
Purpose |
To compare the effects of intensive vs moderate BP control with valsartan on nephropathy and vascular complications in normotensive and hypertensive patients with type 2 diabetes
|
|
Study design |
Randomised
|
|
Follow-up |
5 years
|
|
Patients |
215 patients in the hypertensive cohort
|
|
Treatment regimen |
Intensive (DBP goal 75 mm Hg) or moderate (DBP goal 80-89 mm Hg) BP regimen with valsartan
|
|
Results |
Not yet available
|
|
